VOYA INVESTMENT MANAGEMENT LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,270,552
-29.8%
255,480
+0.4%
0.01%
-22.2%
Q2 2023$7,506,488
+76.3%
254,371
+37.6%
0.01%
+80.0%
Q1 2023$4,258,944
-6.0%
184,850
+13.4%
0.01%
-16.7%
Q4 2022$4,532,919
-7.1%
162,996
+2.6%
0.01%
-14.3%
Q3 2022$4,877,930
-28.2%
158,942
-31.1%
0.01%
-58.8%
Q2 2022$6,793,000
+61.2%
230,830
+76.2%
0.02%
+88.9%
Q1 2022$4,215,000
+169.5%
130,982
+273.5%
0.01%
+200.0%
Q4 2021$1,564,000
-12.9%
35,073
-1.5%
0.00%
-25.0%
Q3 2021$1,796,000
-36.0%
35,591
-0.5%
0.00%
-20.0%
Q2 2021$2,805,000
+78.2%
35,765
+29.7%
0.01%
+66.7%
Q1 2021$1,574,000
-31.3%
27,573
+0.8%
0.00%
-40.0%
Q4 2020$2,291,000
+192.2%
27,350
+25.0%
0.01%
+150.0%
Q3 2020$784,000
+48.2%
21,8820.0%0.00%
+100.0%
Q2 2020$529,000
+20.5%
21,882
-12.8%
0.00%0.0%
Q1 2020$439,000
+8.1%
25,085
+7.7%
0.00%0.0%
Q4 2019$406,000
+36.2%
23,297
+19.9%
0.00%0.0%
Q3 2019$298,000
-26.1%
19,4300.0%0.00%0.0%
Q2 2019$403,000
-6.7%
19,430
+4.5%
0.00%0.0%
Q1 2019$432,000
+12.5%
18,6010.0%0.00%0.0%
Q4 2018$384,000
+5.2%
18,601
+10.7%
0.00%0.0%
Q3 2018$365,00016,7980.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders